Acurx Pharmaceuticals, Inc. (ACXP)

Import this data to Google Sheets with:

=jivedata("ACXP","financials")

Full statements spill as a table. For one cell: =jivedata("ACXP","Revenue") or =jivedata("ACXP","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

Acurx Pharmaceuticals, Inc.

ACXP • CIK 0001736243

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Research and Development Expense	$6,043.597	$5,403.836	$1,834.506	$2,124.501
General and Administrative Expense	$8,534.171	$8,699.267	$6,257.477	$5,544.536
Operating Income (Loss)	—	—	$-8,091.983	$-7,669.037
Operating Expenses	$14,577.768	$14,103.103	$8,091.983	$7,669.037
Net Income (Loss) Attributable to Parent	$-14,577.768	$-14,103.103	$-7,966.538	$-7,506.221
Investment Income, Interest	—	—	$125.445	$162.816
Weighted Average Number of Shares Outstanding, Basic	12,671,572	16,163,366	1,498,793	3,895,417

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash	$7,474.188	$3,706.713	$7,556.1	$10,656.386
Accounts and Other Receivables, Net, Current	$129.159	$51.127	$48.417	$95.307
Assets	$7,709.123	$3,857.963	$7,689.535	$10,984.777
Prepaid Expense, Current	$105.776	$100.123	$85.018	$233.084
Liabilities	$3,042.438	$3,242.842	$2,420.943	$2,832.746
Common Stock, Value, Issued	$14.468	$17.031	$2.348	$4.683
Additional Paid in Capital	$57,871.07	$67,920.046	$80,554.738	$87,370.997
Retained Earnings (Accumulated Deficit)	$-53,218.853	$-67,321.956	$-75,288.494	$-79,223.649
Stockholders' Equity Attributable to Parent	$4,666.685	$615.121	$5,268.592	$8,152.031
Preferred Stock, Shares Authorized	—	—	10,000,000	10,000,000
Preferred Stock, Shares Issued	—	—	0	0
Common Stock, Shares Authorized	200,000,000	200,000,000	250,000,000	250,000,000
Common Stock, Shares, Issued	14,468,229	17,030,686	2,348,113	4,683,253

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$-1,637.563	$-3,767.475	$3,849.387	$4,592.258
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$7,474.188	$3,706.713	$7,556.1	$12,167.026
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$-14,577.768	$-14,103.103	$-7,966.538	$-7,506.221
Net Cash Provided by (Used in) Operating Activities	$-9,800.885	$-10,383.431	$-6,787.782	$-6,183.194
Proceeds from Warrant Exercises	$2,218.999	$210.199	$1,360.544	$1,360.544
Net Cash Provided by (Used in) Financing Activities	$8,163.322	$6,615.956	$10,637.169	$10,775.452
Share-based Payment Arrangement, Noncash Expense	$3,206.527	$2,601.903	$1,247.401	$1,048.411
Increase (Decrease) in Accounts and Other Receivables	$129.159	$-78.032	$-2.71	$55.099
Increase (Decrease) in Prepaid Expense	$-159.179	$-5.653	$-15.105	$179.562
Increase (Decrease) in Accounts Payable and Accrued Liabilities	$980.753	$200.404	$-408.779	$241.219

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("ACXP","financials")

Full statements spill as a table. For one cell: =jivedata("ACXP","Revenue") or =jivedata("ACXP","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.